, BACTEC 460 system (Collins and Franzblau, 1997) , microplate Alamar blue assay (Collins and Franzblau, 1997) , and nitrate reduction (Panaiotov and Kantardjiev, 2002) have been developed. Nonetheless, a common problem with most available methods is that they require the use of virulent M. tuberculosis which precludes their adoption for high-throughput screening. The risk gets further enhanced when one has to screen molecules against drug resistant strains of the pathogen.
In this study we have explored the possibility of identifying a non-pathogenic, fast-growing mycobacterium which, when used in a cell viability based screen, could serve as a 'surrogate' for MDR M. tuberculosis. In this pursuit, we have compared the drug susceptibility profiles of three 'fast grower' mycobacterial species-M. smegmatis, M. phlei and M. foruitum -and found M. smegmatis to show the profile closest to that of MDR clinical isolates of M. tuberculosis. In the follow-up, we have evaluated the potential of M. smegmatis as a primary screen to shortlist compounds which could be active against the drug resistant M. tuberculosis.
Materials and Methods

Mycobacteria. M. tuberculosis H 37
Rv was procured from ATCC (ATCC 27294). The 'fast grower' mycobacteria used in this study were M. fortuitum (TMC 1529), M. phlei (ATCC 1724), and M. smegmatis (ATCC 607).
Three multi-drug resistant (MDR) clinical isolates of M. tuberculosis were provided by the Department of Biotechnology (Government of India) Mycobacterium Repository, located at National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India.
M. tuberculosis was defined by its growth rate, niacin accumulation and HPLC pattern of cell-wall associated mycolic acids (Butler et al., 1996) . The fast growers were defined by their respective biochemical tests and growth patterns at different temperatures.
E. coli. E. coli strain DE3 (Novagen) was used as a 'control' to determine the non-specific antibacterial activity of test compounds.
Working inocula. The mycobacteria were cultured on Lowenstein-Jensen (L-J) medium slants and E. coli was cultured in Luria Bertani (LB) broth. Working inocula were prepared by suspending the cultures in normal saline containing 0.05% Tween-80. To make single cell suspensions, the mycobacteria were agitated vigorously with glass beads. Dilutions of the suspensions were plated on Middlebrook (MB) 7H10 agar medium for counting the colony forming units (CFU) after incubating for the required durations (described below).
Anti-tubercular drugs and test compounds. Isoniazid (INH) and rifampicin (RFM) were purchased from Sigma (USA). The test compounds were 120 molecules synthesized in-house for anti-tubercular activity. Stock solutions of the drugs and test compounds were prepared in dimethyl sulfoxide (DMSO) and stored at Ϫ80°C.
Susceptibility testing. The proportion method (McClachy, 1978) was followed using MB 7H10 agar medium. For tests against M. tuberculosis, the medium was supplemented with OADC (oleic acid, albumin fraction IV, dextrose and catalase). One hundred microliters of serial twofold dilutions of the stock solutions (2 mg/ml) of standard drugs (INH and RFM) or test compounds were incorporated in the medium (final volume: 2 ml/tube) and the tubes were kept in slanting position till the medium solidified.
Working inocula of mycobacteria or E. coli (2ϫ10 7 CFU/ml) were spread on the surface of the medium (10 ml/tube) and tubes were incubated at 37°C. Results were available in 24 h with E. coli, 3 days with M. smegmatis, 5 days with M. fortuitum, 7 days with M. phlei, and 21 days with M. tuberculosis. The least concentration of a drug or compound that completely inhibited the growth of the mycobacteria was recorded as its minimum inhibitory concentration (MIC) with respect to the used inoculum. Sensitivity or resistance towards a drug or compound was determined on the basis of 'Resistance Ratio (RR)' or 'R factor'(ϭMIC of a compound against a given mycobacterium/MIC against M. tuberculosis H 37 Rv). An RR value of 4 or less is taken to denote sensitivity and that of 8 or more denotes resistance (Canetti et al., 1963) .
Statistical analysis. Positive and negative predictive values as well as specificity and sensitivity of the surrogate screen were determined by using a two-bytwo contingency table (Blakely and Salmond, 2002) . From the same table, 'significance of association' was calculated by Chi square test (with Yates' correction) using the web software Graphpad (www.graphpad. com).
Results
Susceptibility of mycobacteria to anti-TB drugs
Initially, sensitivities of M. tuberculosis H 37 Rv, MDR clinical isolates of M. tuberculosis, and the fast grower mycobacteria-M. smegmatis, M. phlei and M. fortuitum were determined against standard anti-TB drugs INH and RFM. Results are depicted in Fig. 1 . MICs of these drugs for M. tuberculosis H 37 Rv were 0.02 and 0.2 mg/ml, respectively (Fig. 1A) . All three MDR isolates showed identical sensitivities (MIC= 25 mg/ml for INH, and 100 mg/ml for RFM) hence only one of them was used for further experiments.
Among the fast growers, M. smegmatis was most resistant to both drugs with a sensitivity profile identical to that of MDR M. tuberculosis in terms of MIC (Fig. 1A) as well as Resistance Ratio (Fig. 1B) . For M. phlei, the MICs of INH and RFM were 12.5 and 0.39 mg/ml; and for M. fortuitum, they were 12.5 and 3.12 mg/ml, respectively. Considering the Resistance Ratios, M. fortuitum was only marginally resistant to RFM (RRϭ15.6, compared to 500 with M. smegmatis) whereas M. phlei was sensitive to RFM (RRϭ1.95). Based on these results, we selected M. smegmatis for evaluation as a possible surrogate screen for compounds which could be active against MDR M. tuberculosis.
Performance of M. smegmatis as a surrogate screen
All test compounds (nϭ120) were inactive (non-inhibitory) against E. coli at 50 mg/ml, which was the highest tested concentration in sensitivity assays. Fifty compounds were considered 'active' against M. tuberculosis H 37 Rv at a cutoff MIC value of Յ12.50 mg/ml, the lowest recorded MIC being Ͻ3.12 mg/ml (Table 1) . MDR M. tuberculosis and M. smegmatis were sensi- tive (RRՅ4) to 27 and 21 of the active compounds, respectively. The overlap between sensitivities of the two microbes was highest (9 out of 9) for compounds having a MIC of 12.5 mg/ml against M. tuberculosis H 37 Rv, followed by those having a MIC of 6.25 mg/ml (7 out of 8) and Ͻ3.12 mg/ml (5 out of 10). The strength of association between MDR M. tuberculosis and M. smegmatis with respect to these results, as calculated from a 2 ϫ2 table (Table 2) , was highly significant (c 2 ϭ27.733, pϽ0.0001).
The specificity of the M. smegmatis based screen was 100% and its sensitivity was 78%, as calculated from the data in Table 2 . 'Positive Predictive Value' of the screen (ϭprobability that sensitivity of M. smegmatis to a compound actually means sensitivity of MDR M. tuberculosis) was 100% and its 'Negative Predictive Value' (ϭprobability that resistance of M. smegmatis to a compound actually means resistance of MDR M. tuberculosis) was 79%. However, the Negative Predictive Value was 100% for the group of 70 compounds which were 'inactive' against M. tuberculosis H 37 Rv (MICϾ12.5 mg/ml), since they were also inactive against both MDR M. tuberculosis and M. smegmatis.
Sensitivity of M. smegmatis in relation to chemical class of compounds
To have an insight into the lesser sensitivity of M. smegmatis (compared with MDR M. tuberculosis) towards some of the test compounds, we considered their chemical structures. All 50 active compounds (except one-a thiourea derivative) fell into two broad categories: (i) amino alkyls and (ii) cyclopropyl methanols. Earlier also our group had reported that amino alkyls having alkyl chains of 8-16 carbon atoms along with aryl/glycofuranosyl/galactopyranosyl moieties are potential anti-tubercular molecules (Katiyar et al., 2005) . The present analysis revealed that 4 out of 6 compounds to which MDR M. tuberculosis was sensitive and M. smegmatis was resistant (Table 2) were amino alkyls with a chain of 12-16 carbon atoms and no point of unsaturation. One of the remaining two compounds was a cyclopropyl methanol and the other, a thiourea derivative.
The 70 test compounds which were inactive against M. tuberculosis H 37 Rv (and also against MDR M. tuberculosis and M. smegmatis) were derivatives of glycosylamine or cyclopropyl methane.
Discussion
There are several reports on the use of Mycobacterium smegmatis as a primary screen to select compounds which could be active against M. tuberculosis (Andries et al., 2005; Lu and Drlica, 2003; Murdock et al., 1978) . However, its utility in screening for compounds active against MDR M. tuberculosis was not explored. We found that the susceptibility of M. smegmatis for the two frontline anti-TB drugs isoniazid and rifampicin was identical to that of MDR clinical isolates of M. tuberculosis. The MICs of the two drugs for M. smegmatis were similar to those reported by Wallace et al. (1988) .
M. smegmatis is known to show a natural resistance towards both INH and RFM (Chung et al , 1995; Li et al , 2004; Quan et al., 1997; Trias and Benz, 1994) . Our results further suggest that the microbe could be naturally resistant to compounds of certain chemical classes. This resistance could be occurring through more than one mechanism. Expression of alkyl hydroperoxide reductase C (ahpC) and INH sensitivity are inversely correlated in mycobacteria. This gene was found inducible in M. smegmatis but not in M. tuberculosis H 37 Rv (Dhandayuthpani et al 1996) . On the other hand, RFM is inactivated by M. smegmatis through ribosylation. Disruption of the gene responsible for this process resulted in mutants having much increased susceptibility to RFM (Dhandayuthpani et al., 1996) . Resistance of M. smegmatis to INH and RFM has also been shown to be contributed by efflux mechanisms (Choudhuri et al , 1999 Li et al., 2004 Piddock et al 2000) .
To conclude, our results demonstrate that M. smegmatis may serve as a highly specific yet stringent screen for selecting molecules which could be active against MDR M. tuberculosis. The stringency (in terms of lower sensitivity) is not necessarily a disadvantage, 
